VIE insider filings
Viela Bio, Inc. — 14 most recent insider filings (SEC Forms 3/4/5) from EDGAR, normalized by FilingPulse. Latest filing: 2021-03-16. Screen VIE transaction legs live →
Insider transaction summary — last 90 days
No insider filings (Forms 3/4/5) for VIE between 2026-08-23 and 2026-11-21. The table below lists the most recent filings on record.
Recent insider filings — Viela Bio, Inc.
| Filed | Form | Insider | Reported transactions | Source |
|---|---|---|---|---|
| 2021-03-16 | 4 | Cao Yanling — Director, 10% owner | Disposition to issuer (D): 8,322,353 @ $53 | EDGAR |
| 2021-03-16 | 4 | Rivers Tyrell — Director | Holdings only — no transactions reported | EDGAR |
| 2021-03-16 | 4 | ASTRAZENECA PLC — 10% owner AstraZeneca UK LTD — 10% owner | Code (U): 14,650,334 @ $53 | EDGAR |
| 2021-03-15 | 4 | Drappa Jorn — Chief Medical Officer | Disposition to issuer (D): 202,661 @ $53 · Disposition to issuer (D): 71,842 (derivative) · Disposition to issuer (D): 64,000 (derivative) · Disposition to issuer (D): 165,000 (derivative) | EDGAR |
| 2021-03-15 | 4 | Chan Mitchell — Chief Financial Officer | Disposition to issuer (D): 37,500 @ $53 · Disposition to issuer (D): 50,056 (derivative) · Disposition to issuer (D): 13,000 (derivative) · Disposition to issuer (D): 30,000 (derivative) · Disposition to issuer (D): 67,500 (derivative) | EDGAR |
| 2021-03-15 | 4 | Kastenmayer James Paul — General Counsel | Disposition to issuer (D): 50,000 (derivative) | EDGAR |
| 2021-03-15 | 4 | Nolet Chris — Director | Disposition to issuer (D): 26,210 (derivative) · Disposition to issuer (D): 7,358 (derivative) | EDGAR |
| 2021-03-15 | 4 | Jacques Rachelle Suzanne — Director | Disposition to issuer (D): 14,716 (derivative) · Disposition to issuer (D): 7,358 (derivative) | EDGAR |
| 2021-03-15 | 4 | Ragatz William — Senior VP, Head of Commercial | Disposition to issuer (D): 16,250 @ $53 · Disposition to issuer (D): 50,548 (derivative) · Disposition to issuer (D): 48,750 (derivative) · Disposition to issuer (D): 13,000 (derivative) | EDGAR |
| 2021-03-15 | 4 | Boundless Meadow Ltd — 10% owner Boyu Capital Fund III, L.P. — 10% owner Boyu Capital General Partner III, L.P. — 10% owner Boyu Capital General Partner III, Ltd. — 10% owner Boyu Capital Opportunities Master Fund — 10% owner Boyu Capital Investment Management Ltd — 10% owner Boyu Capital Group Holdings Ltd. — 10% owner XYXY Holdings Ltd. — 10% owner Tong Xiaomeng — 10% owner | Code (U): 8,322,353 @ $53 · Code (U): 300,000 @ $53 | EDGAR |
| 2021-03-15 | 4 | Wicki Andreas — Director | Disposition to issuer (D): 1,750,000 @ $53 | EDGAR |
| 2021-03-15 | 4 | Yao Zhengbin — Chief Executive Officer, Director | Disposition to issuer (D): 270,219 @ $53 · Disposition to issuer (D): 200,000 @ $53 · Disposition to issuer (D): 188,057 (derivative) · Disposition to issuer (D): 120,000 (derivative) · Disposition to issuer (D): 309,375 (derivative) | EDGAR |
| 2021-03-15 | 4 | Hu Edward — Director | Disposition to issuer (D): 3,953,118 @ $53 · Disposition to issuer (D): 208,059 @ $53 · Disposition to issuer (D): 26,210 (derivative) · Disposition to issuer (D): 7,358 (derivative) | EDGAR |
| 2020-11-18 | 4 | Ren Aaron — See Remarks | Option exercise (M): 2,000 @ $2.84 · Option exercise (M): 2,000 (derivative) @ $2.84 | EDGAR |
Recent 8-K events — Viela Bio, Inc.
Items classified from EDGAR index headers. Browse recent 8-K filings market-wide, by item code →
| Filed | Form | Items reported | Source |
|---|---|---|---|
| 2021-03-15 | 8-K | 2.01 — Completion of Acquisition or Disposition of Assets 3.01 — Notice of Delisting or Failure to Satisfy a Continued Listing Rule or Standard; Transfer of Listing 3.03 — Material Modification to Rights of Security Holders 5.01 — Changes in Control of Registrant 5.02 — Departure of Directors or Certain Officers; Election of Directors; Appointment of Certain Officers; Compensatory Arrangements of Certain Officers 5.03 — Amendments to Articles of Incorporation or Bylaws; Change in Fiscal Year 9.01 — Financial Statements and Exhibits | EDGAR |
| 2021-03-04 | 8-K | 5.02 — Departure of Directors or Certain Officers; Election of Directors; Appointment of Certain Officers; Compensatory Arrangements of Certain Officers 9.01 — Financial Statements and Exhibits | EDGAR |
| 2021-03-01 | 8-K | 2.02 — Results of Operations and Financial Condition 9.01 — Financial Statements and Exhibits | EDGAR |
| 2021-02-16 | 8-K | 2.02 — Results of Operations and Financial Condition | EDGAR |
| 2021-02-01 | 8-K | 1.01 — Entry into a Material Definitive Agreement 5.02 — Departure of Directors or Certain Officers; Election of Directors; Appointment of Certain Officers; Compensatory Arrangements of Certain Officers 8.01 — Other Events 9.01 — Financial Statements and Exhibits | EDGAR |
| 2020-12-08 | 8-K | 5.02 — Departure of Directors or Certain Officers; Election of Directors; Appointment of Certain Officers; Compensatory Arrangements of Certain Officers | EDGAR |
| 2020-11-10 | 8-K | 2.02 — Results of Operations and Financial Condition 9.01 — Financial Statements and Exhibits | EDGAR |
| 2020-11-05 | 8-K | 8.01 — Other Events 9.01 — Financial Statements and Exhibits | EDGAR |
| 2020-09-15 | 8-K | 5.02 — Departure of Directors or Certain Officers; Election of Directors; Appointment of Certain Officers; Compensatory Arrangements of Certain Officers | EDGAR |
| 2020-08-12 | 8-K | 2.02 — Results of Operations and Financial Condition 9.01 — Financial Statements and Exhibits | EDGAR |
Need this as JSON?
GET https://api.filingpulse.io/v1/insider-trades?ticker=VIE returns every filing on this page — normalized, with footnotes and derivative legs — and webhooks push new ones to you in seconds. Get a free API key → · API docs